TRILOGY ACS: Prasugrel 5 mg vs Clopidogrel in ElderlyTRILOGY ACS: Prasugrel 5 mg vs Clopidogrel in Elderly

Cutting its dosage in half for patients aged 75 or older lowered prasugrel's bleeding risk to clopidogrel's risk level while providing comparable clinical benefit in the TRILOGY ACS trial; concerns were that a full prasugrel dosage in the elderly would pose too much of a bleeding risk. Heartwire

Source: Medscape Today Headlines - July 30, 2013 Category: Consumer Health News Tags: Cardiology News Source Type: news